Literature DB >> 8764063

Human T-cell leukemia virus type 2 Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation.

A Bakker1, X Li, C T Ruland, D W Stephens, A C Black, J D Rosenblatt.   

Abstract

The Rex protein is an essential regulator of RNA expression in human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2) that promotes the accumulation of full-length and partially spliced viral transcripts in the cytoplasm. Rex-mediated regulation correlates with specific binding to a cognate RNA recognition element which overlaps the 5' splice site in the viral long terminal repeat. It has been unclear whether Rex directly affects splicing or only nuclear-to-cytoplasmic transport of viral mRNA. We demonstrate that HTLV-2 Rex is a potent inhibitor of splicing in vitro at an early step in spliceosome assembly. Inhibition requires phosphorylation of Rex and the ability of Rex to bind to the Rex response element. Direct inhibition of early spliceosome assembly by Rex may account for differential accumulation of unspliced transcripts and represents a novel mechanism of retroviral gene regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764063      PMCID: PMC190509     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

2.  Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA.

Authors:  T Nosaka; H Siomi; Y Adachi; M Ishibashi; S Kubota; M Maki; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  A simple phase-extraction assay for chloramphenicol acyltransferase activity.

Authors:  B Seed; J Y Sheen
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

4.  Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  HTLV-II transactivation is regulated by the overlapping tax/rex nonstructural genes.

Authors:  J D Rosenblatt; A J Cann; D J Slamon; I S Smalberg; N P Shah; J Fujii; W Wachsman; I S Chen
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

6.  Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.

Authors:  L Rimsky; J Hauber; M Dukovich; M H Malim; A Langlois; B R Cullen; W C Greene
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes.

Authors:  M H Malim; J Hauber; R Fenrick; B R Cullen
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

9.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins.

Authors:  M Hidaka; J Inoue; M Yoshida; M Seiki
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  12 in total

Review 1.  The human T-cell leukemia virus Rex protein.

Authors:  Ihab Younis; Patrick L Green
Journal:  Front Biosci       Date:  2005-01-01

2.  Human T lymphotropic virus type 1 regulatory and accessory gene transcript expression and export are not rex dependent.

Authors:  Min Li; Priya Kannian; Han Yin; Matthew Kesic; Patrick L Green
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-05       Impact factor: 2.205

3.  Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines.

Authors:  R Weil; J P Levraud; M D Dodon; C Bessia; U Hazan; P Kourilsky; A Israël
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs.

Authors:  V Ciminale; L Zotti; D M D'Agostino; L Chieco-Bianchi
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function.

Authors:  M Narayan; K Kusuhara; P L Green
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs.

Authors:  K Kusuhara; M Anderson; S M Pettiford; P L Green
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Human T-cell leukemia virus type 2 Rex carboxy terminus is an inhibitory/stability domain that regulates Rex functional activity and viral replication.

Authors:  Li Xie; Matthew Kesic; Brenda Yamamoto; Min Li; Ihab Younis; Michael D Lairmore; Patrick L Green
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

8.  Multimer formation is not essential for nuclear export of human T-cell leukemia virus type 1 Rex trans-activator protein.

Authors:  P Heger; O Rosorius; C Koch; G Casari; R Grassmann; J Hauber
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Functional domain structure of human T-cell leukemia virus type 2 rex.

Authors:  Murli Narayan; Ihab Younis; Donna M D'Agostino; Patrick L Green
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals.

Authors:  Min Li; Matthew Kesic; Han Yin; Lianbo Yu; Patrick L Green
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.